- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07625826
The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Open Thyroid Surgery
The Effect of Esketamine on Cough Reflex During Tracheal Extubation in Patients Undergoing Open Thyroid Surgery: A Randomized Controlled Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Yun Wu
- Numéro de téléphone: 8613865958254
- E-mail: wuyunanyi@163.com
Lieux d'étude
-
-
Anhui
-
Hefei, Anhui, Chine
- Second Affiliated hospital of Anhui Medical University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Patients scheduled for elective open thyroid surgery
- ASA class I-II
- Voluntarily participate in the study and sign the informed consent form
Exclusion Criteria:
- Body Mass Index > 30 kg/m²
- Patients with unstable ischemic cardiomyopathy, pulmonary hypertension, poorly controlled or untreated hypertension (arterial hypertension, resting systolic/diastolic blood pressure >180/100 mmHg)
- Hepatic or renal dysfunction
- History of oral, maxillofacial, neck, or airway surgery, or pathological structural alterations
- Respiratory diseases (COPD, asthma, inflammation, chronic cough)
- Patients with elevated intracranial pressure
- Patients undergoing repeat surgery
- History of allergy to the investigational drug used in the study
- Patients with psychiatric disorders or alcohol abuse (daily ethanol intake ≥40 g, or having experienced alcohol withdrawal within the past 6 months, or unable to control alcohol consumption)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: ESK iv group
After anesthesia induction, continue to administer esketamine by infusion at 0.1 mg/kg/h during the maintenance phase of anesthesia, and stop the infusion of esketamine during suturing.
|
After anesthesia induction, continue to administer esketamine by infusion at 0.1 mg/kg/h during the maintenance phase of anesthesia, and stop the infusion of esketamine during suturing.
|
|
Comparateur placebo: CON group
After anesthetic induction, an equal amount of saline is continuously infused by pump during the maintenance phase of anesthesia, and the saline infusion is stopped during suturing;
|
After anesthetic induction, an equal amount of saline is continuously infused by pump during the maintenance phase of anesthesia, and the saline infusion is stopped during suturing;
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of coughing during tracheal extubation
Délai: perioperative (From the awakening period to immediately after tracheal extubation)
|
2 point scales; 0=None; 0 = Did not occur; 1 = Occurred;
|
perioperative (From the awakening period to immediately after tracheal extubation)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Severity of coughing during tracheal extubation
Délai: perioperative (From the awakening period to immediately after tracheal extubation)
|
4 grade scales; Grade 0: No choking cough; Grade 1: Single cough episode, considered mild choking cough; Grade 2: Intermittent cough, lasting less than 5 seconds, considered moderate choking cough; Grade 3: Continuous severe cough, lasting more than 5 seconds, considered severe choking cough.
The higher the degree, the worse it is.
|
perioperative (From the awakening period to immediately after tracheal extubation)
|
|
Agitation score during tube removal
Délai: perioperative (From the awakening period to immediately after tracheal extubation)
|
3-level scale; 1: Awake and calm; 2: Mild agitation but can be comforted; 3: Moderate agitation, difficult to comfort; 4: Severe agitation, cannot be comforted; The higher the degree, the worse the situation.
|
perioperative (From the awakening period to immediately after tracheal extubation)
|
|
Blood pressure
Délai: From the induction period until 5 minutes after the completion of surgery
|
Baseline, post-induction, 1 minute after intubation, during suturing, at the end of surgery, 1 minute after extubation, 5 minutes after extubation
|
From the induction period until 5 minutes after the completion of surgery
|
|
Airway pressure 5 minutes after intubation and at the end of surgery
Délai: 5 minutes after intubation and at the end of the surgery
|
5 minutes after intubation and at the end of the surgery
|
|
|
Intraoperative use rate and dosage of vasoactive drugs
Délai: intraoperative (From the induction period to the end of anesthesia)
|
intraoperative (From the induction period to the end of anesthesia)
|
|
|
Sore throat score
Délai: Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
4-point scales; 0 = None; 1 = Mild, milder than a common cold; 2 = Moderate, like a sore throat from a common cold; 3 = Severe, more severe than a common cold; The higher the score, the greater the level of pain.
|
Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
|
Hoarseness scores
Délai: Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
4-point scores; 0 = None; 1 = Transient hoarseness occurs; 2 = Patient perceives hoarseness during visit; 3 = Hoarseness is clearly noticeable; The higher the score, the more severe the hoarseness.
|
Baseline, Immediately postoperatively, 0.5 hours postoperatively, 2 hours postoperatively, 24 hours postoperatively, 48 hours postoperatively
|
|
Surgical area pain scores
Délai: Postoperative day 1 and day 2
|
Pain NRS scale score: 0 = no pain; 1-3 = mild pain; 4-6 = moderate pain; 7-10 = severe pain.
The higher the score, the more severe the pain.
|
Postoperative day 1 and day 2
|
|
Incidence of adverse reactions within 48 hours postoperatively
Délai: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Postoperative nausea and vomiting(PONV) score
Délai: Within day 2 after surgery
|
Vomiting: 0 = None; 1 = Once; 2 = Twice; 3 = Three times or more Nausea, does it affect daily life: 0 = None; 1 = Sometimes; 2 = Often; 3 = Always |
Within day 2 after surgery
|
|
Postoperative analgesic dosage
Délai: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Postoperative time to first food
Délai: perioperative (Time from returning to the ward to the first food)
|
perioperative (Time from returning to the ward to the first food)
|
|
|
Upper Aerodigestive Symptoms After Thyroidectomy (UADS) questionnaire score
Délai: Three month after surgery
|
Upper Aerodigestive Symptoms After Thyroidectomy Questionnaire; Instructions: 0=No problem, 1=Minor, 2=Moderate, 3=Major. Voice symptoms
|
Three month after surgery
|
|
Heart rate
Délai: Time Frame: From the induction period until 5 minutes after the completion of surgery
|
Baseline, post-induction, 1 minute after intubation, during suturing, at the end of surgery, 1 minute after extubation, 5 minutes after extubation
|
Time Frame: From the induction period until 5 minutes after the completion of surgery
|
|
Oxygen saturation
Délai: Time Frame: From the induction period until 5 minutes after the completion of surgery
|
Baseline, post-induction, 1 minute after intubation, during suturing, at the end of surgery, 1 minute after extubation, 5 minutes after extubation
|
Time Frame: From the induction period until 5 minutes after the completion of surgery
|
|
Anesthesia time
Délai: perioperative (Time from induction to discontinuation of anesthetic agents)
|
perioperative (Time from induction to discontinuation of anesthetic agents)
|
|
|
Surgery time
Délai: From the start of surgery to the end of surgery
|
From the start of surgery to the end of surgery
|
|
|
Extubation time
Délai: perioperative (The time from discontinuation of anesthetic drugs to extubation)
|
perioperative (The time from discontinuation of anesthetic drugs to extubation)
|
|
|
Duration of tracheal tube placement
Délai: perioperative (Time from intubation to )
|
perioperative (Time from intubation to )
|
|
|
Awakening time
Délai: perioperative (Stop the anesthesia drug injection until awakening time)
|
perioperative (Stop the anesthesia drug injection until awakening time)
|
|
|
Post-anesthesia care unit (PACU) stay time
Délai: perioperative (Duration from entering the PACU to leaving the PACU)
|
perioperative (Duration from entering the PACU to leaving the PACU)
|
|
|
PACU RASS score
Délai: perioperative (Record once every ten minutes from the time of entering the post-anesthesia care unit until leaving the recovery room.)
|
|
perioperative (Record once every ten minutes from the time of entering the post-anesthesia care unit until leaving the recovery room.)
|
|
Intraoperative doses of propofol
Délai: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of remifentanil
Délai: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of Non-Steroidal Anti-Inflammatory Drugs(NSAIDs)
Délai: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative doses of sufentanil
Délai: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative fluid volume
Délai: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Intraoperative blood loss
Délai: Intraoperative (From the induction period to the end of anesthesia)
|
Intraoperative (From the induction period to the end of anesthesia)
|
|
|
Sleep scores
Délai: Postoperative 24 hours and 48 hours
|
4 point scores; 1 = Good sleep; 2 = Restless sleep; 3 = Dreamy sleep; 4 = Insomnia; The higher the score, the poorer the sleep.
|
Postoperative 24 hours and 48 hours
|
|
Antiemetic drug dosage
Délai: Within day 2 after surgery
|
Within day 2 after surgery
|
|
|
Postoperative time to ambulation
Délai: Perioperative (From the operating room to discharge)
|
Perioperative (From the operating room to discharge)
|
|
|
Length of postoperative hospital stay
Délai: Perioperative (From the operating room to discharge)
|
Perioperative (From the operating room to discharge)
|
|
|
Postoperative time to first water intake
Délai: Perioperative (Time from returning to the ward to the first drink of water)
|
Perioperative (Time from returning to the ward to the first drink of water)
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- YX2026-124
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .